R & D
Synedgen’s research and development is focused on developing novel therapies and products through its proprietary technologies based on natural biopolymers. Synedgen takes the natural pathogen-evading polymers found in nature and modifies them to enhance their activity and bioavailability through chemical modification. These deriviatives are highly effective against bacteria, yet are biocompatible, nontoxic and biodegradable.
Platform Technology
Synedgen has a robust development process across multiple indications utilizing potent, bio-friendly antibacterial compounds. We concentrate on developing new options for the management of drug resistant and emerging pathogens and biofilms in medicine, agriculture and the environment:
Pharmaceutical/Medicine
- New strategies that disrupt and remove potentially lethal bacterial biofilms from wounds, implantable devices and skin
- Oral rinse products that dissolve the biofilms in the mouth that lead to plaque, gingivitis and periodontitis
- Wound treatments that prevent biofilm formation and treat highly infectious and contagious MRSA and Acinetobacter without limiting healing
- Pre-surgical rinses that reduce the bacteria that cause secondary infections in hospitals, the 4th largest killer in the US
- Treatments for gastrointestinal infection that result from overuse of oral antibiotics
- Treatments for pulmonary infections where biofilms limit the effectiveness of traditional antibiotics, block airways and cause high mortality
Agriculture
- Food and water additives that will replace antibiotics in poultry and other farm animals
- New treatments that will control pathogens in food animals and pets
- Non-toxic, biocompatible products to prevent food contamination such as E. coli and salmonella
Environment
- Environmentally safe surface sanitizers that will reduce the burden of pathogenic bacteria on walls and surfaces in hospitals, nursing homes and common areas
- New treatments for water lines and medical equipment to reduce biofilms and bacterial contamination